Unretirement Wave Older Americans Return to Workforce Driven by Financial Needs and Purpose UK Spy Chief Warns of Moment of Consequence as Russia and China Threats Mount Lululemon Shares Gain as Company Reaches Proxy Settlement with Founder Chip Wilson Extra EU Border Checks Suspended at Dover Potential Disruption for CrossChannel Ferry Operators and Travel Industry Bond Markets Bet on Sustained Inflation Raising Pressure on Washington Policymakers AppLovin Shares Rally Past Key Technical Level Following Bullish Analyst Outlook Marker Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Pipeline Progresses Rapid7 Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction Wayfair Q1 2026 Earnings EPS Slightly Misses Estimates Amid Ongoing Market Challenges SPCB Q4 2025 Earnings Stunning EPS Beat Surprises Market CDZI Q1 2026 Earnings Narrowing Loss Beats Estimates Amid Revenue Uncertainty IMNN Q1 2026 Earnings Narrowerthanexpected loss drives small share gain NetScout Systems NTCT Edges Higher Amid Steady Trading Key Levels in Focus PPlus Tr GSC2 Ctf Fltg Rate PYT Holds Near 2339 as Flat Session Reflects Steady Demand FBS Global Limited FBGL Gains Momentum After 1034 Surge Organon Co OGN Holds Steady Near Support as Market Digests Flat Trading Session IDEAYA Biosciences IDYA Hovers Near Resistance After Modest Pullback Indias Satirical Cockroach Party Faces Website Blocking Raising Digital Freedom Concerns Gogoro Inc Q1 2026 Earnings EPS of 048 Reported Amidst Operational Transition Nuveen AMTFree Municipal Credit Income Fund NVG Edges Higher Amid Steady Trading CINF Q1 2026 Earnings EPS Surpasses Estimates by 573 Amid Mixed Market Reaction Neogen Corporation NEOG Q1 2026 Earnings Strong Profit Beat Offsets Flat Revenue SCVL Q1 2026 Earnings EPS Slightly Misses Estimates Stock Jumps on Resilient Demand Immunovant Q1 2026 Earnings Wider Than Expected Loss Amid No Revenue AMWD Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction Supernus Pharmaceuticals SUPN Q1 2026 Earnings Robust EPS Beat Overshadowed by Mild Share Decline ADMA Biologics Q1 2026 Earnings EPS Miss Weighs on Shares as Profitability Path Remains in Focus